Ordenar

Buscar

01/03/2026 Economic Burden of Hidradenitis Suppurativa in Spain
Vilarrasa, E, Borrás-Blasco, J, Lobo-Benito, S, Loro-Pérez, M, Núñez-García, MG, Oliva-Moreno, J, Palacios-Martínez, D, Rubial-Bernárdez, F, Ivanova-Markova, Y, Daheron, M, Bellas, J, Martorell, A. Economic Burden of Hidradenitis Suppurativa in Spain. Dermatology and Therapy. 2026; 16(3)DOI:10.1007/s13555-026-01669-2. PMID:41723775. IF:4.200(Q1/1D).
01/03/2026 Real-world data support restaging at reTURB for prognostic re-stratification of EAU 2021 risk groups in high-grade T1 non-muscle-invasive bladder cancer: A data-driven, risk-adapted guide to timely radical cystectomy decisions
Diaz, AFM, Henriquez, JDS, Ojeda, CM, Medina, AA, Duran, PD, Serrano, GM, Dos Santos, VG, Krajewski, W, Pichler, R, Scilipoti, P, Longoni, M, De Angelis, M, Moschini, M, Velasco, JC, Aumatell, J, Contieri, R, Gallioli, A, Slusarczyk, A, Grobet-Jeandin, E, Del Giudice, F, Soria, F, Mertens, L, Pradere, B, Revilla, FJB. Real-world data support restaging at reTURB for prognostic re-stratification of EAU 2021 risk groups in high-grade T1 non-muscle-invasive bladder cancer: A data-driven, risk-adapted guide to timely radical cystectomy decisions. EUROPEAN UROLOGY. 2026; 89DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2026 Sasanlimab plus bacillus Calmette-Guérin in BCG-naive, high-risk non-muscle-invasive bladder cancer (NMIBC): Exploratory biomarker analysis of the phase 3 CREST trial.
Galsky, MD, Lin, GHY, Shore, ND, Steinberg, GD, Bedke, J, Palou, J, Brinkmann, J, Calella, AM, Cesari, R, Davis, C, Rosenthal, S, Yang, WJ, Ching, KA, Saul, M, Vasaikar, SV, Powles, T. Sasanlimab plus bacillus Calmette-Guérin in BCG-naive, high-risk non-muscle-invasive bladder cancer (NMIBC): Exploratory biomarker analysis of the phase 3 CREST trial.. JOURNAL OF CLINICAL ONCOLOGY. 2026; 44(7_SUPPL)DOI:10.1200/JCO.2026.44.7_suppl.806. PMID:. IF:41.900(Q1/1D).
01/03/2026 Risk of recurrence and progression after endoscopic kidney-sparing surgery for upper tract urothelial carcinoma: An EAU-YAU urothelial proposal
Gallioli, A, Di Bello, F, D'Andrea, D, Zattoni, F, Soria, F, Krajewski, W, Laukhtina, E, Marcq, G, Moschini, M, Izquierdo, P, Afferi, L, Mari, A, Del Giudice, F, Dieguez, L, Donnini, I, Avesani, G, Subiela, G, Basile, G, De Lorenzis, E, Chung, B, Territo, A, Palou, J, Pradere, B, Breda, A. Risk of recurrence and progression after endoscopic kidney-sparing surgery for upper tract urothelial carcinoma: An EAU-YAU urothelial proposal. EUROPEAN UROLOGY. 2026; 89DOI:. PMID:. IF:25.200(Q1/1D).